COBRA

Carfilzomib, Lenalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide and Dexamethasone (KRd vs. VRd) in Patients With Newly Diagnosed Multiple Myeloma (COBRA)

More Information

Trial Status
Active, Not Recruiting
Trial Phase
Phase 3
Enrollment
250 patients (estimated)
Sponsors
University of Chicago Medicine
Tags
Proteasome Inhibitor
Trial Type
Treatment
Last Update
2 months ago
SparkCures ID
1007
NCT Identifier
NCT03729804

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.